Sorrento Therapeutics Inc (SRNE)
0.0137
-0.01
(-31.50%)
USD |
OTCM |
Apr 26, 15:54
Sorrento Therapeutics Total Assets (Quarterly): 456.69M for June 30, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2023 | 456.69M |
| March 31, 2023 | 460.06M |
| December 31, 2022 | 472.84M |
| September 30, 2022 | 615.61M |
| June 30, 2022 | 632.13M |
| March 31, 2022 | 855.64M |
| December 31, 2021 | 694.82M |
| September 30, 2021 | 752.79M |
| June 30, 2021 | 778.92M |
| March 31, 2021 | 613.62M |
| December 31, 2020 | 535.82M |
| September 30, 2020 | 602.08M |
| June 30, 2020 | 533.07M |
| March 31, 2020 | 536.55M |
| December 31, 2019 | 557.63M |
| September 30, 2019 | 560.88M |
| June 30, 2019 | 587.04M |
| March 31, 2019 | 609.47M |
| December 31, 2018 | 624.09M |
| September 30, 2018 | 587.96M |
| June 30, 2018 | 452.52M |
| March 31, 2018 | 436.88M |
| December 31, 2017 | 431.61M |
| September 30, 2017 | 484.78M |
| June 30, 2017 | 384.77M |
| Date | Value |
|---|---|
| March 31, 2017 | 345.23M |
| December 31, 2016 | 401.59M |
| September 30, 2016 | 279.06M |
| June 30, 2016 | 351.40M |
| March 31, 2016 | 273.78M |
| December 31, 2015 | 343.52M |
| September 30, 2015 | 325.30M |
| June 30, 2015 | 132.82M |
| March 31, 2015 | 131.26M |
| December 31, 2014 | 141.54M |
| September 30, 2014 | 104.13M |
| June 30, 2014 | 110.32M |
| March 31, 2014 | 90.62M |
| December 31, 2013 | 92.58M |
| September 30, 2013 | 37.98M |
| June 30, 2013 | 7.789M |
| March 31, 2013 | 12.20M |
| December 31, 2012 | 6.782M |
| September 30, 2012 | 7.892M |
| June 30, 2012 | 8.917M |
| March 31, 2012 | 3.724M |
| December 31, 2011 | 4.569M |
| September 30, 2011 | 3.311M |
| June 30, 2011 | 3.896M |
| March 31, 2011 | 5.592M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
456.69M
Minimum
Jun 2023
855.64M
Maximum
Mar 2022
602.72M
Average
587.04M
Median
Jun 2019
Total Assets (Quarterly) Benchmarks
| Scilex Holding Co | 101.31M |
| AIM ImmunoTech Inc | 19.38M |
| Perspective Therapeutics Inc | 97.89M |
| Protalix BioTherapeutics Inc | 84.43M |
| Armata Pharmaceuticals Inc | 98.36M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 654.65M |
| Shareholders Equity (Quarterly) | -205.11M |
| Debt to Equity Ratio | -0.6928 |
| Current Ratio | 0.5024 |
| Net Debt Paydown Yield | 1.11% |